Vimta Labs Ltd
NSE:VIMTALABS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
397.8933
877.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Vimta Labs Ltd
Vimta Labs Ltd. engages in the provision of contract research and testing. The company is headquartered in Hyderabad, Telangana and currently employs 1,273 full-time employees. The Company’s business includes analytical, clinical, preclinical services to life sciences industries; quality and safety testing for food and beverage industries; and environment services to a wide spectrum of industries. The firm provides services of testing and contract research in the fields of analytical food and water, preclinical research, clinical research, biopharma, environmental assessments and clinical reference lab. The company supports regulatory authorities in mandatory certification of food and agricultural products exported from India. The company assists the food industry for nutritional labelling, food safety evaluations, trace analysis and shelf life studies. Its environmental services include site selection and liability studies; environmental impact assessments; environment management plans and carrying capacity-based regional studies.
Vimta Labs Ltd. engages in the provision of contract research and testing. The company is headquartered in Hyderabad, Telangana and currently employs 1,273 full-time employees. The Company’s business includes analytical, clinical, preclinical services to life sciences industries; quality and safety testing for food and beverage industries; and environment services to a wide spectrum of industries. The firm provides services of testing and contract research in the fields of analytical food and water, preclinical research, clinical research, biopharma, environmental assessments and clinical reference lab. The company supports regulatory authorities in mandatory certification of food and agricultural products exported from India. The company assists the food industry for nutritional labelling, food safety evaluations, trace analysis and shelf life studies. Its environmental services include site selection and liability studies; environmental impact assessments; environment management plans and carrying capacity-based regional studies.
Record Revenue: Vimta Labs delivered its highest-ever quarterly revenue in Q2 FY '26 with INR 104.5 crores, up 22.3% year-on-year.
Strong Margins: EBITDA margin for the quarter was 35.3%, and PAT margin stood at 19.1%.
Growth Drivers: Pharmaceutical research and food testing services remained the main contributors to revenue growth.
Capacity Expansion: Recent infrastructure expansion means no immediate capacity constraints; about 50–60% of new space is already in use.
Biologics Progress: Biologics contract research facility is on schedule to be ready by the end of Q3 FY '26 and commercialized by Q1 FY '27.
CapEx Plans: INR 47 crores spent in H1 FY '26; full-year CapEx expected around INR 100 crores, with INR 25 crores per year planned for biologics.
Export Growth: Export share increased slightly to about 32% of revenue, with domestic and export growth both contributing.
Outlook: Management is targeting an annualized run rate of INR 500 crores and sees no major margin improvements expected from current levels.
